In-vitro evaluation of anti-inflammatory and anti-SARS-CoV-2 effect of a chemically characterized hydroalcoholic extract of poplar type propolis

In my talk I'd like to present the recent data published from my team and colleagues of INMI Spallanzani (Rome) in Biomedicines (IF: 5.61) and Frontiers in Microbiology (IF: 5.64) about the very interesting effect of a chemically characterized Euroasian propolis extract in vitro tests. In detail we demonstrated the superiority of the whole phytocomplex compared to single compound in inhibiting overexpression of pro-inflammatory cytokines in LPS-stimulated human PMBC and for its anti Sars-CoV2 effect.

Molecular mechanism will be elucidated.

Back to blog